Uploaded December 2025 | Updated September 2026, 2 weeks ago
Choosing a CDMO isn’t just a technical decision — it shapes speed to market and how well regenerative medicine serves patients.
Jacqueline Schmit explains why expertise in biomaterials, regulation, and reimbursement is essential, and why the best partners keep the patient at the center of every step.
Choosing a CDMO isn’t just a technical decision — it shapes speed to market and how well regenerative medicine serves patients.
Jacqueline Schmit explains why expertise in biomaterials, regulation, and reimbursement is essential, and why the best partners keep the patient at the center of every step.









 Kunststoffe, die Leben retten: 100 Jahre Materialinnovation.](https://i.ytimg.com/vi/kFGIAHW_r0Q/mqdefault.jpg)
